The measurable acute or chronic release of Somatotropin, commonly known as Growth Hormone (GH), elicited by the administration or presence of a secretagogue agent. This response reflects the functional capacity of the somatotroph cells in the anterior pituitary to release GH in response to appropriate hypothalamic stimulation. Clinical evaluation assesses the magnitude of this secretory burst.
Origin
‘Somatotropin’ is the formal name for Growth Hormone, while ‘secretagogue’ refers to a substance that promotes secretion, derived from Greek roots. This response is a critical indicator of pituitary health and the integrity of the GH/IGF-1 axis. The term focuses specifically on the secretory event itself.
Mechanism
Secretagogues typically act by inhibiting somatostatin, the primary inhibitory signal from the hypothalamus, or by directly stimulating G-protein coupled receptors on the somatotrophs. A robust response indicates that the pituitary cells are sensitive to regulatory input and possess adequate stores of pre-formed GH. Poor response often suggests somatotroph exhaustion or upstream hypothalamic dysfunction.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.